Nephrology/Urology Flashcards
Electrolyte requirements
Na - 1 mEq/kg
K - 2 mEq/kg
Cl - 3 mEq/kg
Volume of distribution
0.6 x wt x 1L/kg
Osmolarity calculation
2NA + BUN/2.6 + glucose/18
Electrolyte disturbances in hypernatremic dehydration
Hyperglycemia, hypocalcemia
FENa calculation
(Una x Pcr)/(Ucr x Pna)
FENa in prerenal AKI
< 1%
RAS stimulation
decreased renal perfusion
Angiotensin II effects
vasoconstriction, renal effects (efferent vasoconstriction, Na reabsorption, aldosterone secretion), ADH secretion
Aldosterone effects
Na reabsorption, K secretion
ANP effects
vasodilation, renal effects (dilates afferent/constricts efferent, decrease Na reabsorption, decrease RAS)
Diagnosis of nephrotic syndrome
Proteinuria (> 40 mg/mg2/hr)
Edema
Elevated cholesterol
False positive for protein on UA
pH > 7.5
FSGS diagnosis
Nephrotic syndrome NOT responsive to steroids
FSGS prognosis
50-70% progress to CKD (30% relapse in transplant)
Nephrotic syndrome causes
Primary (90%) - MCD»_space;> FSGS > MPGN
Secondary (10%) - HSP, SLE, HUS
Renal disease with decreased C3
PSGN, MPGN, SLE nephritis
Congenital nephrotic syndrome genetics
AR
Congenital nephrotic syndrome findings
Oligohydramnios, large placenta, presentation < 1 yo, death by E. coli sepsis
MCD age group
preschool
Complications of MCD
peritonitis (s. pneumo, e. coli), thrombosis
Treatment of refractory MCD
cyclophosphamide, cyclosporine
Most common vasculitis in children
HSP
HSP pathogenesis
IgA deposition
HSP findings
Palpable purpura, abdominal pain (intussusception), arthralgia/arthritis, renal dz
HSP diagnosis
clinical (biopsy reserved for atypical cases)
Indications for glucocorticoids in HSP
abdominal pain (NOT indicated for renal dz)
Recurrence rate of HSP
up to 1/3 (screen with UA every 6 mo)
HUS findings
microangiopathic hemolytic anemia, AKI, thrombocytopenia
HUS prognosis
5% mortality, 5% complictions